首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1643897

全球診斷皮膚科設備市場 - 2025-2033

Global Diagnostic Dermatology Equipment Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球診斷皮膚科設備市場在2024年達到108億美元，預計2033年將達到224億美元，2025-2033年預測期間複合年成長率為5.9%。

診斷皮膚科設備市場是一個至關重要的領域，它使用各種工具和技術來識別、監測和評估皮膚病，如皮膚癌、牛皮癬、濕疹和色素沉著障礙。這些設備（如皮膚鏡、反射共焦顯微鏡和光學相干斷層掃描）可提供準確、非侵入性的早期診斷，進而改善患者的治療效果。該市場由人工智慧整合和遠端皮膚科解決方案等技術進步推動。該行業在皮膚病護理中發揮關鍵作用，彌合了傳統方法與現代、數位和人工智慧驅動的解決方案之間的差距。

市場動態：

驅動程式和限制

皮膚病的盛行率不斷增加

痤瘡、牛皮癬、濕疹和黑色素瘤等皮膚疾病的日益流行推動了診斷皮膚科設備的全球市場，這些疾病由於污染、生活方式的改變和長時間暴露在陽光下等因素而變得更加普遍。世界衛生組織報告稱，皮膚病每年影響數百萬人，導致對皮膚鏡、影像系統和活體組織切片設備等先進診斷工具的需求。人們對皮膚健康和常規皮膚病檢查的認知不斷增強，進一步鼓勵了這些設備的採用，確保了市場的成長。

例如，根據美國皮膚病學會的數據，痤瘡是美國最常見的皮膚病，每年影響多達 5,000 萬美國人。存在不同類型的痤瘡，因此一刀切的方法並不適用。經過委員會認證的皮膚科醫生可以根據皮膚類型和痤瘡類型進行診斷並確定適當的治療方法。有多種治療方法可供選擇，包括口服藥物、外用藥物、非處方藥和處方藥。痤瘡通常始於青春期並影響青少年和年輕人，但可以發生在生命的任何階段。成人痤瘡持續增加，影響高達 15% 的女性。大約 85% 12-24 歲的人會出現輕微痤瘡。

皮膚科診斷設備成本高昂

包括皮膚鏡、共焦顯微鏡和成像系統在內的診斷皮膚科設備的高成本是市場成長的主要障礙，特別是在低收入和中等收入地區。這些先進的工具前期費用昂貴，因此較小的診所和醫療機構不太容易使用它們。維護和營運費用也增加了財務負擔，進一步限制了它們的採用。在醫療保健預算有限或不優先考慮皮膚科服務的地區，這個問題尤其成問題。

FotoFinder Systems GmbH
3Derm Systems, Inc.
HEINE Optotechnik GmbH & Co. KG
AMD Global Telemedicine, Inc.
Hill-Rom Holdings, Inc.
Derma Medical Systems
Leica Microsystems
Caliber ID (Formerly Lucid, Inc.)
GE Healthcare
Similar data will be provided for each market player.
VivaScope 有限公司
- 管道產品說明
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估算與預測
維里斯金公司
視覺Dx
FotoFinder 中心
遠端皮膚
將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄

Product Code: MD9062

The global diagnostic dermatology equipment market reached US$ 10.8 Billion in 2024 and is expected to reach US$ 22.4 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.

The diagnostic dermatology equipment market is a crucial sector that uses various tools and technologies to identify, monitor, and evaluate skin conditions like skin cancer, psoriasis, eczema, and pigmentation disorders. these devices, like dermatoscopes, reflectance confocal microscopes, and optical coherence tomography, provide accurate, non-invasive, and early diagnosis, improving patient outcomes. the market is driven by technological advancements, such as ai integration and teledermatology solutions. the sector plays a critical role in dermatological care, bridging the gap between traditional methods and modern, digital, and ai-driven solutions.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Skin Disorders

The global market for diagnostic dermatology equipment is driven by the increasing prevalence of skin disorders like acne, psoriasis, eczema, and melanoma, which are becoming more prevalent due to factors like pollution, lifestyle changes, and prolonged sun exposure. The World Health Organization reports that skin diseases affect millions annually, leading to a demand for advanced diagnostic tools like dermatoscopes, imaging systems, and biopsy devices. The growing awareness of skin health and routine dermatological checkups further encourages the adoption of these devices, ensuring market growth.

For instance, according to American Academy of Dermatology Association, Acne is the most common skin condition in the US, affecting up to 50 million Americans annually. Different types of acne exist, making a one-size-fits-all approach unsuitable. A board-certified dermatologist can diagnose and determine the appropriate treatment based on the skin type and acne type. There are various treatments available, including oral, topical, over-the-counter, and prescription medications. Acne typically begins in puberty and affects adolescents and young adults, but can occur at any stage of life. Adult acne continues to increase, affecting up to 15% of women. Approximately 85% of people aged 12-24 experience minor acne.

High Cost of Diagnostic Dermatology Equipment

The high cost of diagnostic dermatology equipment, including dermatoscopes, confocal microscopes, and imaging systems, is a major obstacle to market growth, especially in low- and middle-income regions. These advanced tools are expensive upfront, making them less accessible to smaller clinics and healthcare facilities. Maintenance and operational expenses also add to the financial burden, further limiting their adoption. This issue is particularly problematic in areas with limited healthcare budgets or where dermatological services are not prioritized.

Segment Analysis

The global diagnostic dermatology equipment market is segmented based on product type, technology, Application, end user and region.

Product Type:

Imaging Devices segment is expected to dominate the Diagnostic Dermatology Equipment market share

The imaging devices segment holds a major portion of the diagnostic dermatology equipment market share and is expected to continue to hold a significant portion of the diagnostic dermatology equipment market share during the forecast period.

The imaging devices segment is a key player in the global diagnostic dermatology equipment market, offering accurate and non-invasive visualization of skin conditions. It includes devices like dermatoscopes, confocal microscopes, and multispectral imaging systems, which diagnose various dermatological disorders like melanoma, eczema, and psoriasis. These devices provide high-resolution images and advanced features like digital storage and AI-driven analytics. The growing prevalence of skin disorders and advancements in imaging technologies drive demand for these devices.

For instance, in June 2023, DeepX Diagnostics has received FDA clearance for its digital dermatoscope DermoSight, a tool for teledermatology screening of suspected skin cancer lesions in the US.

Hence, the FDA cleared DeepX Diagnostics' DermoSight digital dermatoscope in June 2023, indicating the growing use of advanced imaging tools in teledermatology, especially for skin cancer screening. This approval boosts the credibility and market potential of digital dermatoscopes, boosting healthcare provider trust and driving global imaging device growth.

End User:-

Hospitals segment is the fastest-growing segment in diagnostic dermatology equipment market share

The hospitals segment is the fastest-growing segment in the diagnostic dermatology equipment market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the global diagnostic dermatology equipment market, focusing on diagnosing and managing complex conditions like melanoma, psoriasis, and eczema. They invest heavily in advanced diagnostic tools like imaging devices, biopsy systems, and AI-powered solutions to improve skin disease detection accuracy. Hospitals also adopt teledermatology platforms to enhance accessibility and patient outcomes. The rising prevalence of skin disorders and demand for specialized dermatological care are driving their contributions to market growth.

For instance, in January 2025, Lux Hospitals in Hyderabad has introduced the ENDOANAL Real-Time Ultrasound-Guided Laser Procedure for treating Fistula in Ano, pioneered by Dr. Samhitha Reddy Marpali. With over eight years of experience, Dr. Marpali specializes in treating various proctology disorders, including Piles, Fistulas, Anal Fissures, Pilonidal Sinus, Colon and Rectum Cancers, and other complex colorectal conditions. She offers world-class care to patients.

Geographical Analysis

North America is expected to hold a significant position in the Diagnostic Dermatology Equipment market share

North America holds a substantial position in the diagnostic dermatology equipment market and is expected to hold most of the market share due to due to its advanced healthcare infrastructure, FDA approvals, product launches, advanced technologies, increased awareness about early diagnosis and preventive dermatology, favorable reimbursement policies, key market players, and ongoing R&D initiatives, which contribute to its market leadership.

For instance, in June 2024, the US FDA has approved DermaSensor, the first AI-enabled medical device for skin cancer detection in primary care. This marks a new regulatory precedent for medical devices incorporating AI and ML technologies in dermatology. The device, already approved in the European Union and Australia, is considered a milestone in the industry, highlighting the clinical evidence and regulatory implications of AI-enabled technologies.

Europe is growing at the fastest pace in the Diagnostic Dermatology Equipment market

Europe holds the fastest pace in the diagnostic dermatology equipment market and is expected to hold most of the market share due to increasing incidence of skin diseases like atopic dermatitis and psoriasis, supported by government initiatives and public health campaigns. The aging population and well-established healthcare systems contribute to increased demand for advanced diagnostic tools. Investments in dermatology-focused research and development further support market expansion.

For instance, Eczema, also known as atopic dermatitis, is a prevalent skin disease in the UK, affecting 1 in 5 children and 1 in 10 adults. It is the leading contributor to skin-related disability, with severe cases more likely to develop depression. The disease burden is highest in disability-adjusted life-years (DALYs).

Hence, the disease contributes to skin-related disability and severe complications like depression, necessitating advanced diagnostic tools for early detection and effective management. The burden of disability-adjusted life-years underscores the need for accurate and efficient dermatological solutions, driving demand for innovative equipment in clinical and research settings.

Competitive Landscape

The major global players in the diagnostic dermatology equipment market include Canfield Scientific, Inc, FotoFinder Systems GmbH, 3Derm Systems, Inc, HEINE Optotechnik GmbH & Co. KG, AMD Global Telemedicine, Inc., Hill-Rom Holdings, Inc., Derma Medical Systems, Leica, Microsystems, Caliber I.D. (Formerly Lucid, Inc.), GE Healthcare and among others.

Key Developments

In October 2024, The American Academy of Dermatology is launched an initiative to highlight the debilitating condition of hidradenitis suppurativa (HS), a chronic progressive condition causing painful bumps in the armpits, thighs, and groin. HS is often misdiagnosed or undiagnosed, leading to scarring, pain, and impaired mobility. Patients with HS often suffer from depression, self-esteem issues, and daily living challenges, including work.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diagnostic dermatology equipment market report delivers a detailed analysis with 70 key tables, more than 69 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Skin Disorders
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Diagnostic Dermatology Equipment
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Imaging Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Microscopy Devices
6.4. Biopsy Devices
6.5. Other Diagnostic Devices

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Digital Imaging*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. AI-Powered Diagnostic Tools
7.4. Optical Imaging
7.5. Molecular Imaging

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Skin Cancer Diagnosis*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Psoriasis Diagnosis
8.4. Eczema Diagnosis
8.5. Acne Diagnosis
8.6. Pigmentation Disorders Diagnosis
8.7. Vascular Lesions Diagnosis
8.8. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Dermatology Clinics
9.4. Ambulatory Surgical Centers
9.5. Research Laboratories

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Canfield Scientific, Inc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. FotoFinder Systems GmbH
12.3. 3Derm Systems, Inc.
12.4. HEINE Optotechnik GmbH & Co. KG
12.5. AMD Global Telemedicine, Inc.
12.6. Hill-Rom Holdings, Inc.
12.7. Derma Medical Systems
12.8. Leica Microsystems
12.9. Caliber I.D. (Formerly Lucid, Inc.)
12.10. GE Healthcare
Similar data will be provided for each market player.

Emerging Market Players

12.11. VivaScope GmbH*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. Veriskin, Inc.
12.13. VisualDx
12.14. FotoFinder Hub
12.15. TeleSkin
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE